Synthesis of benzoylpyrimidines as antagonists of the corticotropin-releasing factor-1 receptor

被引：8
|
作者：
Webb, TR
Moran, T
Huang, CQ
McCarthy, JR
Grigoriadis, DE
Chen, C
机构：
[1] Neurocrine Biosci Inc, Dept Med Chem, San Diego, CA 92121 USA
[2] Neurocrine Biosci Inc, Dept Pharmacol, San Diego, CA 92121 USA
来源：
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2004年 / 14卷 / 15期
关键词：
benzoylpyrimidine; CRF; antagonist;
D O I：
10.1016/j.bmcl.2004.05.072
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
A series of benzoylpyrimidines derived from the anilinepyrimidine CRF1 antagonists were synthesized. Several synthetic routes were developed to explore the SAR of this series of compounds. Compounds such as 8d (K-i = 15 nM) exhibited high binding affinities at the human CRF1 receptor. (C) 2004 Elsevier Ltd. All rights reserved.
引用
收藏
页码：3869 / 3873
页数：5
相关论文
共 50 条
  • [21] Design, synthesis and structure-activity relationships of 5-alkylaminoquinolines: Potent, orally active corticotropin-releasing factor-1 receptor antagonists
    Takeda, Kunitoshi
    Terauchi, Taro
    Hashizume, Minako
    Shikata, Kohdoh
    Taguchi, Ryota
    Murata-Tai, Kaoru
    Fujisawa, Masae
    Takahashi, Yoshinori
    Shin, Kogyoku
    Ino, Mitsuhiro
    Shibata, Hisashi
    Yonaga, Masahiro
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2014, 247
  • [22] Corticotropin-Releasing Factor Acting on Corticotropin-Releasing Factor Receptor Type 1 is Critical for Binge Alcohol Drinking in Mice
    Kaur, Simranjit
    Li, Ju
    Stenzel-Poore, Mary P.
    Ryabinin, Andrey E.
    ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2012, 36 (02) : 369 - 376
  • [23] Mechanism of corticotropin-releasing factor type I receptor regulation by nonpeptide antagonists
    Hoare, SRJ
    Sullivan, SK
    Ling, N
    Crowe, PD
    Grigoriadis, DE
    MOLECULAR PHARMACOLOGY, 2003, 63 (03) : 751 - 765
  • [24] Synthesis and structure-activity relationship of imidazo[1,2-a]benzimidazoles as corticotropin-releasing factor 1 receptor antagonists
    Han, XJ
    Pin, SS
    Burris, K
    Fung, LK
    Huang, S
    Taber, MT
    Zhang, J
    Dubowchik, GM
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2005, 15 (18) : 4029 - 4032
  • [25] Synthesis and SAR of 8-arylquinolines as potent corticotropin-releasing factor1 (CRF1) receptor antagonists
    Huang, CQ
    Wilcoxen, K
    McCarthy, JR
    Haddach, M
    Webb, TR
    Gu, J
    Xie, YF
    Grigoriadis, DE
    Chen, C
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2003, 13 (19) : 3375 - 3379
  • [26] Pain is a salient "stressor" that is mediated by corticotropin-releasing factor-1 receptors
    Hummel, Michele
    Cummons, Terri
    Lu, Peimin
    Mark, Lilly
    Harrison, James E.
    Kennedy, Jeffrey D.
    Whiteside, Garth T.
    NEUROPHARMACOLOGY, 2010, 59 (03) : 160 - 166
  • [27] Corticotropin-releasing factor-1 receptor antagonists decrease heroin self-administration in long- but not short-access rats
    Greenwell, Thomas N.
    Funk, Cindy K.
    Cottone, Pietro
    Richardson, Heather N.
    Chen, Scott A.
    Rice, Kenner C.
    Zorrilla, Eric P.
    Koob, George F.
    ADDICTION BIOLOGY, 2009, 14 (02) : 130 - 143
  • [28] Modulation of prostaglandin synthesis in endothelial cells and fibroblasts by corticotropin-releasing factor and antagonists
    Fleisher-Berkovich, S
    Rimon, G
    Danon, A
    FOURTH INTERNATIONAL CONGRESS ON ESSENTIAL FATTY ACIDS AND EICOSANOIDS, 1998, : 96 - 98
  • [29] Synthesis, Structure-Activity Relationships, and In Vivo Evaluation of N3-Phenylpyrazinones as Novel Corticotropin-Releasing Factor-1 (CRF1) Receptor Antagonists
    Hartz, Richard A.
    Ahuja, Vijay T.
    Arvanitis, Argyrios G.
    Rafalski, Maria
    Yue, Eddy W.
    Denhart, Derek J.
    Schmitz, William D.
    Ditta, Jonathan L.
    Deskus, Jeffrey A.
    Brenner, Allison B.
    Hobbs, Frank W.
    Payne, Joseph
    Lelas, Snjezana
    Li, Yu-Wen
    Molski, Thaddeus F.
    Mattson, Gail K.
    Peng, Yong
    Wong, Harvey
    Grace, James E.
    Lentz, Kimberley A.
    Qian-Cutrone, Jingfang
    Zhuo, Xiaoliang
    Shu, Yue-Zhong
    Lodge, Nicholas J.
    Zaczek, Robert
    Combs, Andrew P.
    Olson, Richard E.
    Bronson, Joanne J.
    Mattson, Ronald J.
    Macor, John E.
    JOURNAL OF MEDICINAL CHEMISTRY, 2009, 52 (14) : 4173 - 4191
  • [30] Blocking corticotropin-releasing factor-2 receptors, but not corticotropin-releasing factor-1 receptors or glucocorticoid feedback, disrupts the development of conditioned defeat
    Cooper, Matthew A.
    Huhman, Kim L.
    PHYSIOLOGY & BEHAVIOR, 2010, 101 (04) : 527 - 532
12345